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A .  BACKGROUND 
1. ARC History in Cardiovascular (CV) Instrumentation 
D e v e l o p m e n t  
The Ames Research Center (ARC) has a long history in the development of 
CV instrumentation for human and animal research. The ARC 
Cardiovascular Research Lab under the Space Physiology Branch, Space 
Research Directorate, supports both ground-based and space-based animal 
and human research goals. The Cardiovascular Research Laboratory was 
established at ARC in the mid-1960's to conduct ground-based animal 
research and support development of advanced cardiovascular 
instrumentation applicable to spaceflight. The ARC Biomedical Research 
Program also conducts human studies with a CV instrumentation focus. 
Specific instrumentation developed at ARC has included items ranging 
from long-duration, flexible, dry EKG electrodes for animal or human use to 
an inductively-powered, implantable, multi-channel telemetry system for 
Rhesus monkeys which measures the EKG, mean aortic pressure, mean left 
ventricular pressure, and intrathoracic temperature. A carotid blood flow 
and pressure cuff developed for Rhesus monkeys flew on Cosmos 
biosatellite missions 1514, 1667 and is proposed for a 1989 Cosmos 
mission in modified form. 
2 .  Need for ReviewlCoordination of Future CV Instrumentation 
D e v e l o p m e n t  
Based on the ARC expertise in CV instrumentation development and the 
high science priority of cardiovascular research in the support of man-in- 
space for extended durations, the Life Sciences Projects Office (LSPO) held 
a conference to review the status of current and proposed R & D efforts 
both within and outside of NASA. A recent JSC-sponsored Workshop was 
also held for this purpose which focused on human, on-invasive CV 
instrumentation for Space Station. A list of proposed LSPO experiment 
payloads with a cardiovascular focus, current estimated flight dates and 
associated animal specimens is shown in Table 1. 
To evaluate the status of CV instrumentation development, the Conference 
was conducted at ARC on July 21-22, 1987 to which NASA Primary 
Investigators and their engineering support personnel, representatives of 
the bioinstrumentation development and manufacturing community and 
NASA science and engineering management were invited. A list of the 42 
attendees is included in Attachment 1. A similar evaluation was 
conducted for ARC by a NASA contractor about 10 years ago. 
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TABLE 1 
CARDIOVASCULAR FLIGHT EXPERIMENTS 
Mission Date PVAdvisor Species 
Cosmos '89 1989 Vamer 
SLS- 1 1990 Hutchins 
Popovic 
SLS-2 1992 Hutchins 
Popovic 
Moore-Ede 
IML-2 1992 Vatner 
Moore-Ede 
SLS-3 1993 Moore-Ede 
Rhesus monkey 
Rat 
Rat 
Rat 
Rat 
Squirrel monkey 
Rhesus monkey 
Rhesus monkey 
Squirrel monkey 
. 
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B CV BIOINSTRUMENTATION CONFERENCE GOALS 
The two major goals for the ARC CV Bioinstrumentation Conference are 
listed below with corresponding sub-goals. 
1 Review Science Requirements/Instrumentation Capabilities 
Review proposed cardiovascular science requirements 
Assess science requirement commonality across species 
Review current instrumentation capabilities 
Assess instrumentation R & D required for accurate, precise 
measurements of cardiovascular parameters in the space craft 
2 .  Assess Instrumentation Development Methods/Coordination 
Options 
Assess modes for increased scientist/technologist interaction 
Review options for joint NASA/Industry R & D cooperation 
Assess ARC CV Bioinstrumentation Conference as model for 
improving R & D coordination 
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C . REQUIREMENTS/C APABILITIES SUMMARY 
1 . Cardiovascular Science Requirements 
Presentations were given by NAS A-sponsored Primary Investigators and/or Science Advisors to 
define science requirements for their animal specimens of choice. These are briefly listed below 
and are summarized by measurement parameter and specimen type in Table 2. 
R. Ballard - NASA Ames Research Center, Moffett Field, CA 
Introduction 
S. Vatner - Harvard Medical School, Southboro, MA 
Blood pressure 
Blood flow 
Cardiac dimensions 
Specimen: Rhesus monkey 
S. Churchill (M. Moore-Ede) - Harvard Medical School, Boston, MA 
Blood pressure 
Heart m e  
Chronic catheters for blood sampling, fluid volumes 
Specimen: Rhesus monkey/squirrel monkey 
P. Hutchins - Bowman Gray School of Medicine, Winston-Salem, NC 
Blood pressure 
Blood flow 
Microvascular dimensiondmorp hology 
Fluid volumes 
Specimen: Rat . 
V. Popovic - Emory University, Atlanta, GA 
Vascular catheters for blood sampling 
Blood flow 
Specimen: Rat 
4 
J. Buckey - University of Texas, Dallas, TX 
Baroreflex test 
Cardiac output 
Central venous pressure 
Specimen: Human 
Viewgraphs and/or handouts available from the science presentations are 
included as Attachment 3. 
2 .  Instrumentation Capabilities 
Presentations were given by bioinstrumentation industry representatives 
on their cardiovascular sensor systems potentially applicable to use in 
spaceflight. These are briefly listed below and are summarized in Table 3 
into five measurement types with technology options. Viewgraphs and/or 
handouts from the industry presentations are included in Attachment 4. 
H. Finger - NASA Ames Research Center, Moffett Field, CA 
Introduction 
R. Eberhart - Johns Hopkins Univ., Laurel, MD 
Biomedical implantable devices for fluid sampling 
Medication/materials compatibility studies 
Multichannel implantable telemetry system (temperature, 
EKG, blood pressures, flow) - PATS 
Non-thrombogenic, biocompatible catheter materials 
Microelectronics lab for development (future) 
C. Drost - Transonic Systems, Inc., Ithaca, NY 
Transit-time implantable blood flowmeter (volume flow) 
B. Brockway - Data Sciences, Roseville, MN 
Small animal implantable telemetry (piezo-resistive blood 
pressure sensor via fluid-filled catheter, EKG, heart rate) 
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TABLE 2 
C ARDIOV ASCUL ARIFLUID-ELECTROLYTE MEASUREMENTS 
RHESUS SQUIRREL RAT HUMAN 
MONKEY M O W  
MEASURE= 
P r e s s u r e :  
X X 
(Non- invas ive)  
X 
X 
X Aorta 
Mean Arterial 
Left Ventricular 
Right Atrial (CVP) X 
X 
X X X 
X 
F l o w :  
Ascending Aorta (co) X X 
Regional- Blood 
R e n a l  
Mesenter ic  
I l l i ac  
B r a i n  
Hea r t  
Carotid 
Femoral  
Microcirculation 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X X X 
X 
X 
Left Ventricular S ize  
EKG 
U r i n e  
X 
X 
X 
X 
X 
X 
Fluid Compartments:  
ECF 
PV 
TBW 
BV (by location) 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Regiona l  Compl iance :  
v e n o u s  
p e r i p h e r a l  
c e n t r a l  
t i s sue  
X X X 
X 
X 
. 
Blood: X X 
X 
X 
X 
X ( I n  vitro) X ( In  vitro) 
S e r u m  
Gasses, pH 
Ions (Na+, K+, Ca++) 
CVP = Central Venous Pressure; CO = Cardiac Output: ECF = Extracellular Fluid; PV = 
Plasma Volume; TBW = Total Body Water, BV = Blood Volume 
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E. Luzzi - L & M Electronics, Daly City, CA 
Automated blood flow/pressure system for spaceflight 
(external to vessel, hardware implant) 
C. Parker - Millar Instruments, Houston, TX 
Catheter-tip implantable blood pressure/doppler flow 
systems for animal/human use (existing device is acute 
implant, but chronic implant is planned) 
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PRESSURE 
TABLE 3 
TRANSDUCER CANDIDATES 
Indwelling pressure sensor 
External sensor with fluid filled catheter 
Piezoresist ive 
Capacitative 
Lase r  
Fiber optic 
Magnetoresis t ive 
FLOW 
Doppler - pulse 
Doppler - CW (continuous wave) 
Doppler - Optical laser 
Electromagnetic Flowmeter 
Trans i t  - t i me 
Thermal Dilution 
Ultrasonic  
Mic rosphe re  
CARDIAC DIMENSION 
Ultrasonic crystals (instantaneous cardiac dimensions) 
Piezoelectric film devices 
Imaging ultrasound 
Fast computed tomography (CT) 
Magnetic nuclear resonance (MRI) 
MICROCIRCULATION 
Implantable video sensors 
EKG 
Telemetry 
2 vs. 3 lead 
Hardwired (cutaneous/subcutaneous implant) 
D. SPLINTER GROUP MEETINGS 
Splinter group meetings were held on the development of science requirements and priorities 
(SCIENCE SPLINTER GROUP) and instrumentation development methods/coordination options 
(HARDWARE SPLINTER GROUP). 
1. Science Splinter Group 
The summary results from the review of science requirements and related issues/concerns are 
grouped by measurement type, below. 
PRESSURE 
A. SCIENCE REQUIREMENTS (1) - ARTERIAL PRESSURE 
SPECIES: Rhesus monkey/squi.ml monkey, rat 
MEASUREMENT LOCATION Aorta, Left Ventricle 
ATTACHMENT TECHNIQUE: Intravascular, with non-fluid filled lines 
SIZE: TBD, 1 mm or less in diameter for rats 
SENSOR STABILI'IY: need 1-2 mm Hg/month, predictable linear zero drift 
B. SCIENCE REQUIREMENTS (2) - VENOUS PRESSURE 
SPECIES: Rhesus monkey/squirrel monkey, rat 
MEASUREMENT LOCATION: Central venous location (right atrium) 
ATTACHMENT TECHNIQUE: Intravascular, with fluid-filled lines desired initially, as 
blood sample is typically desired, later, solid-state non-fluid filled lines will be 
preferable. 
SIZE: TBD 
SENSOR STABILITY: 0.5-1.0 mm Hgmonth, predictable linear zero drift 
C. IS SUES/CONCERNS 
c Stable baseline!lpredictable drift 
Fibrotic coating at blood interface 
Sensitivity and resolution 
Automatic compensation for: (with same accuracy and stability as sensor) 
thoracic pressure 
ambient pressure changes 
Sizing for animals down to the size of adult rodents 
Telemetered applications desirable with little or no acute catheterization needs 
Blood sampling method 
Maintain bioisolation 
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FLOW 
A. SCIENCE REQUIREMENTS (1) - AORTIC (CARDIAC OUTPUT) 
Species: Rhesus monkey, rat 
MEASUREMENT LOCATION: Aorta 
ATTACHMENT TECHNIQUE: Extravascular 
SIZE: TBD, vessel diameter as small as 2 mm 
SENSOR STABILITY: TBD, ideally f2 d m i n  per month 
B. SCIENCE REQUIREMENTS (2) - REGIONAL (Renal, Mesenteric, Iliac) 
SPECIES: Rhesus monkey, squirrel monkey, rat 
MEASUREMENT LOCATION: Renal, Mesenteric, Iliac Arteries 
ATTACHMENT TECHNIQUE: Extravascular 
SIZE: TBD, 1 mm or less in diameter for rats 
SENSOR STABILITY: Accurate zero required, stability is TBD 
I C. ISSUES/CONCERNS 
Vessel deformation and/or restriction 
Most advantageous technology, not chronically implantable 
Sensitivity to turbulence/flow velocity profile 
Reduced power consumption 
Size constraints 
Electromagnetic compatibility 
Compatibility with pressure and dimension measurements 
Positioning errorshite stability 
Site availability 
D. SCIENCE REQUIREMENTS (3) - REGIONAL (Brain, Heart) 
SPECIES: Rhesus monkey, squirrel monkey, rat 
MEASUREMENT LOCATION Brain, Coronary Arteries 
ATTACHMENT TECHNIQUE: Microsphere injection, Imaging (MRI, PET, CT) 
SIZE: TBD 
SENSOR STABILW TBD, accommodate calibration 
E. ISSUES/CONCERNS 
Radioactivityflsotopes 
Catheterization 
Animalsacrifice 
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CARDIAC DIMENSION 
1 A. SCIENCE REQUIREMENTS - LEFT VENTRICULAR DIMENSION 
SPECIES: Rhesus monkey, squirrel monkey, rat, human 
MEASUREMENT LOCATION Left Ventricle 
AmACHMENT TECHNIQUE: Direct implant of ultrasonic crystals; Non-invasive 
SIZE: TBD 
SENSOR STABILITY: TBD, ideally fo.01 mdmonth 
Echocardiogram or fast CI' 
B. ISSUES/CONCERNS 
Compatibility with flow measurements 
Instantanmus and continuous 
Reduced power consumption and size for telemetry 
Need Left ventricular and End diastolic pressure simultaneously 
MICROCIRCULATION 
A. SCIENCE REQUIREMENTS -MICROCIRCULATION MORPHOLOGY 
SPECIES: Rhesus monkey, squirrel monkey, rat 
MEASUREMENT LOCATION: Subcutaneously 
AlTACHMENT TECHNIQUE: TBD, currently videomonitor but ideally direct video 
SIZE: 10 mm dia. x 2 mm thick 
SENSOR STABILITY: Ideally S.001 d m o n t h  
implant 
B. ISSUES/CONCERNS 
Data rate 
size 
Power Consumption 
EKG 
A. SCIENCE REQUIREMENTS -ELECTROCARDIOGRAM 
SPECIES: Rhesus monkey, squirrel monkey, rat 
MEASUREMENT LOCATION: Subcutaneously 
ATTACHMENT TECHNIQUE: Subcutaneous 
SIZE: Three lead Biopotential 
SENSOR STABILITY: N/A 
B. ISSUES/CONCERNS 
Data rate (wave farm vs. event) 
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COMMON ISSUES/CONCERNS 
Schedule  
P o w e r  
Size 
Sensitivity and Resolution 
Drift/Stability 
Calibration frequency/procedures 
Measurement resolution accuracy 
Implant duration (9 - 18 months) 
technical issues 
biocompatiblity issues 
Fret-ranging vs. restrained subjects 
Bioisolation (fluid-filled catheter vs. electrical lines, etc.) 
Failure Mode Effects Analysis 
Crew safety 
Automation vs. crew time 
Data rate 
2 .  Hardware Splinter Group 
A CV Sensor/Transducer Assessment form was filled out for each 
transducer candidate identified by the Workshop participants which was 
judged applicable to one of the five cardiovascular measurement types 
reviewed. For each sensor/transducer type, the form included an 
assessment of Measurement Site/Vessel; AttachmentlImplant Method; 
Development Status (near-term, long-term); Advantages/Disadvantages 
and Recommendations. These assessments are included as Attachment 2. 
Two highly-applicable CV instrumentation assessment reports prepared 
recently for ARC were obtained after the Workshop and utilized as 
additional sources for preparation of the assessments. A brief description 
of each of the sensor/transducer technologies is given below. 
CV SENSOR/TRANSDUCER TECHNOLOGY DESCRIPTIONS 
PRESSURE 
1. Piezo-resistive semiconductor 
Commonly used transducer which consists of a diaphragm with attached 
semiconductor strain gauges. Requires a micropower amplifier and is often 
used with other sensors in a multi-channel application. The low milliwatt 
bridge excitation voltage can be duty-cycled to conserve power while 
providing continuous data output. Konigsberg Instruments, Inc. makes a 
titanium diaphragm with stainless steel leads in sizes from 3.5 to 7.0 mm 
dia. available as combination pressure transducer/EKG electrodes. 
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Transducers have standard calibration range of 0 to +300 mm Hg and 0 to 
+lo0 mm Hg. Typical drift is 3-20 mm Hg/month for smaller and 1-6 mm 
Hg/month for larger transducers. 
2. Pressure-sensitive capacitor 
A variation on 1, above, where a pressure-sensitive capacitor is used. 
Stanford Univ. has worked on an implantable, micropowered IC for this 
type of sensor. 
3. Fiber optic LED 
Camino Labs in San Diego has a commercial product using this technique. 
The sensor is sealed and built into the tip of an intravascular catheter (as 
small as #4 French). Light is transmitted down an optical fiber to a gold- 
plated sealed metal bellows which has a reflective surface facing the 
interior of the catheter. The bellows is exposed to the blood (or other 
fluid) on the outside of the catheter and senses the pressure changes which 
produce movement of the reflective surface. A receiving optical fiber 
transmits reflected light down the catheter to an external photo diode/LED 
device which converts light energy to electrical energy. Has been used in 
humans and animals as small as large rats. Pressure range is -10 to 200 
mm Hg, drift is quite stable after 24-48 hours (3 mm Hg) and is only 
moderately temperature sensitive (2-3 mm Hg shift from 70 -1050 F). 
4. Fiber optic laser - TBD 
A similar technique to fiberoptic LED except based on laser technology. 
commercial product yet developed. 
No 
5 .  Magneto-resistive - TBD 
FLOW 
1. Electromagnetic 
Utilizes principle that an electromotive force is produced when a conductor 
moves in a magnetic field. Typically the magnetic coil is placed in a cuff 
around the vessel to be monitored as are two sensing electrodes which 
must be in electrical contact with the vessel. The electrodes sense an EMF 
which is proportional to flow velocity. They are made with either AC field 
coils or permanent magnets. Probes come in wide variety of sizes since 
they do require a snug fit to the vessel. The AC field coil requires a four 
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conductor cable with shielding which can be relatively stiff. The DC 
permanent magnet requires no power and only two cable leads but has 
less baseline stability. Interference with other electrical signals (Le., EKG) 
in same area is possible. 
2. Ultrasound, transit-time 
Utilizes alternating pulse-catch ultrasonic technology to measure the 
difference between the time it takes a sound wave to travel a fixed 
reflective pathway through a moving fluid in the direction of the flow and 
the time necessary for the beam to travel the same pathway in the 
opposite direction (against the flow). Transit-time varies with the average 
flow velocity encountered by the ultrasound. The use of wide-beam 
transducer crystals creates an ultrasonic beam which includes the entire 
cross-sectional area of the flow in a way analogous to integrating a narrow 
beam over the width of the vessel. Hence volume flow, not velocity, is 
measured directly in a manner independent of both velocity flow profile 
and vessel cross-sectional area. The reflective pathway crosses the flow 
twice to yield a measure of flow essentially independent of vessel-probe 
alignment and flow turbulence. Good zero stability. Uses relatively loose- 
fitting, non-constrictive probe which requires only acoustic contact with 
the vessel. Allows for long-term implantability with vessel growth and 
pulsatile diameter changes. Requires 4-strand microfine (1 mm total o.d., 
including insultation and jacket) flexible cable. 
3. Pulse doppler 
Similar to 4, below, but utilizes only one crystal. Provides flow velocity 
only. Less acoustical and electrical interference with other sensors than 
CW doppler. Both 
methods have good frequency response. 
Has a high velocity limitation (such as rat aortic flow). 
4. Continuous wave (CW) doppler 
Utilizes bi-directional doppler technique (two crystals) to sense frequency 
shift due to moving blood. Provides flow velocity only and probe must be 
snug fit. Good baseline stability and has a definite zero flow capability. 
Relatively lightweight and flexible probes. 
5.  Optical laser doppler - TBD 
6. Thermal dilution, microsphere injections - TBD 
7. Microspheres - TBD 
14 
1 CARDIAC DIMENSIONS 
I 1. Ultrasonic crystals - TBD 
2. Piezoelectric film - TBD 
3. 
resonance (MRI) - TBD 
Imaging ultrasound, fast computer tomography (CT), magnetic nuclear 
MICROCIRCULATION 
1. Video sensor - TBD 
2. Laser doppler - TBD 
1. 2 lead 
Well-developed sensor technologies which typically use highly-flexible 
leads made by coiling stainless steel wires in silastic tubing. Require only 
micropower amplifiers and are often used with other sensors i n .  multi- 
channel applications. Heart rate is typically derived from EKG usually at 
the receiver. Two-lead systems will give an approximation of the EKG 
wave useful for calculating heart rate. 
2. 3 lead 
The same technology as 1, above, but the third lead acts as an inactive 
electrode thus providing an EKG wave which can reflect cardiac conduction 
events. 
E RECOMMENDATIONS 
1. Science Splinter Group Recommendations 
What type of program should be developed f o r  technology 
de v e 1 op m e n t I b io co mp a t i b i 1 it y testing ? 
New technology development should be driven by peer-reviewed scientific 
objectives and requirements. Such hardware should be tested and 
approved by the Investigators using the technology and accepted as valid 
by their science peers. 
Should NASA establish a continued interaction between the scientific and 
commercial communities? I f  so, how? 
Yes, continued communication between the scientific and commercial 
communities is critical. 
Throughout the NASA design/development process (Phases A-D), 
interested parties (NASA, Investigators, crew and manufacturers) must 
continually interact to produce the most effective end product. This 
process must include prototype production and the final product must be 
capable of being upgraded as the technology evolves. Sufficient numbers 
of the prototypes and final products must be manufactured for 
Investigator use, crew training, ground testing, control studies flight. 
2 .  Hardware Splinter Group Recommendations 
This Group strongly endorsed the recommendations above from the 
Science Splinter Group. In addition, they addressed the questions below. 
How useful is the workshop format f o r  identifying instrumentation 
requirements and potential teams for hardware *development? 
It is critical that scientist/technologist interaction on the issue of 
bioinstrumentation development for spaceflight occur within the context of 
NASA's flight program constraints in order to maximize early development 
of usable systems. NASA should consider the option of identifying science 
and technology advisors for specific areas of bioinstrumentation who have 
significant knowledge of NASA's programmatic issues in addition to 
specific technical knowledge. These advisors could provide planning 
support for both NASA and industry by ensuring that science and 
hardware requirements are clearly defined and NASA programmatic issues 
such as performance specifications, budget and schedule are known. 
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The workshop format seems ideal for identifying top-level requirements, 
identifying areas of expertise, and potential teams for supporting and 
conducting hardware development. Some technical experts identified but 
not in attendance at a given workshop, should be contacted after so they 
can be included in the developing network. 
What is the relat ion between special-purpose N A S A  f l i gh t  
bioinstrumentation and larger market commercial versions? 
A strong recommendation was made for ensuring maximum linkage 
between the development of NASA spaceflight instrumentation and 
commercial instrumentation to allow future upgrades of NASA technology 
as they are developed for commercial markets. The concept of flight 
qualifying commercial hardware was recommended as one method to 
ensure this linkage. This concept consists of modifying commercial 
hardwarehoftware to meet flight requirements to the maximum degree 
possible. This process will require close coordination between NASA and 
industry. 
What options exist for NASAlindustry research and development 
coop e ration ? 
New mechanisms available for NASA support of industry 
' bioinstrumentation R & D for spaceflight were identified such as SBIR 
grants. Industry representatives recommended that NASA encourage 
informal industry proposals suitable for preliminary review and provision 
of an industry support system if more elaborate proposals are required to 
meet complex government contracting requirements. New NASA/industry 
joint venture agreements available through the NASA Commercial 
Programs Office were considered viable options for cooperative 
development. Assuming strong interest by both parties, industry would be 
amenable to providing their resources in  a cost-sharing manner with 
NASA. 
3 .  Additional Recommendations 
What is  the relation between bioinstrumentation development for human 
and animal subjects? 
Based on the list of cardiovascular-related science measurements proposed 
for spaceflight listed in Table 2 above, it is apparent that there is strong 
interest in utilizing subjects ranging from rodents to humans for a given 
measurement. This requirement has a long history in the biological 
sciences and not surprisingly continues as a viable concept in  the 
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spaceflight era. The challenge for spaceflight bioinstrumentation 
developers is to provide maximum utilization of common and even 
commercial equipment along with specimen-unique sensor development in 
order to ensure high flexibility in  applications with the lowest 
development cost. 
What cardiovascular sensors appear to be good options for near-term 
development based on the science return on investment? 
Additional analysis of the technologies identified will be required to make 
comprehensive recommendations in this area. In general, however, blood 
pressure and blood flow sensors appear to be near-term technology 
candidates which could benefit strongly from NASA-sponsored 
development. Another area which appears to be a likely candidate for 
near-term development is pre/postflight cardiac dimensions measured by 
n on- i nv as ive imaging methods . 
What constitutes a cardiovascular sensor? 
The need for developing not just sensors but "sensor systems" was 
recommended for implantable cardiovascular instrumentation. These 
"systems" would include at a minimum transducers, fixtures, packaging, 
leads, connectors and feedthroughs. Improvements in the design and 
integration of these elements can be as important as breakthroughs in 
transducer development. 
18 
F. ATTACHMENTS 
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AGENDA 
CARDIOVASCULAR BIOINSTRUMENTATION MEETING 
NASA-AMES RESEARCH CENTER 
JULY 21-22, 1987 
TUESDAY, JULY 21 
0830 Opening Remarks R. Ballard, ARC 
0900 Presentations by Scientists S. Vatner, Harvard 
S. Churchill, Harvard 
P. Hu tc hins , B o wm an- Gray 
V. Popovic, Emory 
J. Buckey, Univ. of Texas 
1030 
1045 
Break 
Presentations by Bioinstrumentation- H. Finger, ARC 
Engineering Representatives Russell Eberhart, JHU 
Cor Drost, Transonics Corp 
David Osgood, Mini-Mitter 
Ed Luzzi, L&M Electronics 
C. Parker, Millar 1nst.Inc. 
1200 Lunch 
1300 Bioinstr-Engineering Presentations cont'd. 
1400 Open Discussion 
WEDNESDAY, JULY 22 
0830 Splinter Groups: Science Interests C. Fuller/R. Ballard 
Hardware Interests R. Mains/H. Finger 
1300 Reports from splinter groups 
1430 Summary and Recommendations 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood Pressure 
SENSOWNSDUCER TYPE: Piezo-resistive semiconductor 
MEASUREMENT SITE/VESSEL: Arteries/veins of TBD size 
ATTACHMENTDMPLANT METHOD: Direct intravascular or external via intravascular fluid- 
Nled catheter, extravascular aplanation 
DEVELOPMENT STATUS: 
1. Near-term 
available technology, chronically implantable inside vessels of 7 mm &a. and larger 
drift of 1-2 mm Hg/month (best case) 
about 2.5 mm dia. minimum with acceptable drift 
signal conditioning developed, telemetry already developed 
extravascular aplanation method used with Rhesus monkeys in Cosmos Biosatellite 
Project for 60-90 day duration 
fluid-filled intravascular catheters (arterialhenous) with external transducers proposed 
for Squirrel monkeys on SLS- 1 flight 
2. Long-term 
may eventually yield to more stable measurement methods 
with partial duty cycle could be good candidate far totally implanted telemetry 
systems using power vests to allow free-ranging subjects 
ADVANTAGES/DISADVANTAGES :
applicability to rodents difficult because of small vessels 
good candidate for next 5 years 
requires sensor selection after testing to get highest performance 
fabrication methods (packaging) need improvement 
automotive industry has commercial interest 
typically requires restrained subjects for continuous monitoring due to signal conditioning 
RECOMMENDATIONS 
assess large industry interest and involvement to improve packaging and 
interchangeability 
well-established technology can likely be improved 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood pressure 
SENSOFWRANSDUCER TYPE: Fiber optic LED 
MEASUREMENT SITE/VESSEL: Arteries/vcins as small as 1 mm dia. 
ATTACHMENT/IMPLANT METHOD: Direct intravascular 
DEVELOPMENT STATUS: 
1. Near-term 
commerically available from Camino Labs, San Diego 
current drift is moderate after first 48 hours 
used for only 72 hours chronically exposed to blood due to clotting, 5-7 
days for cerebral spinal fluid 
2. Long-term 
long-duration chronic application is TBD 
ADVANTAGESIDIS ADVANTAGES: 
good potential for low drift 
signal processing requirements moderate 
suitability for chronic application is TBD 
RECOMMENDATIONS: 
technology simple and reliable 
need evaluation for use in chronic application 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood pressure 
SENSOR/TRANSDUCER TYPE: Pressure-sensitive capacitor 
MEASUREMENT SITEWESSEL: Arterieslveins as small as 1 mm dia. 
ATTACHMENTflMPLANT METHOD: Direct intravascular or external via 
intravascular fluid-filled catheter, extravascular aplanation 
DEVELOPMENT STATUS: 
1. Near-term 
Konigsberg tested 7 mm dia. intracranial unit in past 
with 1 mm Hghonth  drift 
Stanford University (Smith/Meindl) working on implantable, 
micro-powered IC with pressure-sensitive capacitor 
Pacesetter, Inc. and Case Western Univ. may have done some 
R & D  
2. Long-term 
potential for low-power. low-drift, simple fabrication 
signal conditioning relatively complex 
ADVANTAGESKIIS ADVANTAGES : 
could be as small as 1 mm dia. 
low drift potential good 
packaged into a single IC for telemetry 
RECOMMENDATIONS: 
good candidate for near-term development (within 5 years) 
review current development efforts (see above) 
good return potential for early investment in R & D. 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood pressure 
SENSOIUIRANSDUCER TYPE: Fiber optic laser 
MEASUREMENT SITE/VESSEL: Arteries/veins as small as 1 mm dia. 
ATTACHMENTDMPLANT METHOD: 
DEVELOPMENT STATUS: 
Direct intravascular, others TBD 
1. Near-term 
beyond current state-of-an 
current drift is about 3 mm Hg/day 
high power consumption would require duty-cycling 
2. Long-term 
telemetry application would require much work due to 
high power consumption 
ADVANTAGES/DIS ADVANTAGES : 
good potential for low drift 
signal processing requirements average 
high power consumption and drift requires R & D 
RECOMMENDATIONS: 
good candidate for long-term development only 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood pressure 
SENSORERANSDUCER TYPE: Magneto-resistive 
MEASUREMENT S I T E W S E L :  
ATTACHMENTAMPLANT METHOD: 
DEVELOPMENT STATUS: 
1. Near-term 
Honeywell has done some R & D and unit available 
2. Long-term 
TBD 
ADVANTAGESDIS ADVANTAGES : 
requires low power 
RECOMMENDATIONS: 
possibility for early development, needs evaluation 
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CARDIOVASCULAR SENSORlTRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood flow 
SENSOWRANSDUCER TYPE: Electromagnctic 
MEASUREMENT SITEFESSEL: Aneries and veins as small as 2.5 mm 
dia. 
ATTACHMENTflMPLANT METHOD: In contact with vessel wall exterior 
DEVELOPMENTSTATUS: 
1. Near-term 
System being developed/tested for SLS-1 rodent PI at ARC 
using hardwire connection via tether 
Honeywell has system which assumes zero in late diastole 
high drift, high power consumption problems 
thickens arterial wall from current fields 
2. Long-term 
ADVANTAGESIDIS ADVANTAGES: 
high drift, high power consumption 
not useful in small vessels due to high zero offset drift 
biocompatibility concerns 
affects other electrical measurements (ECG, etc.) 
RECOMMENDATIONS: 
monitor evaluation underway at ARC for SLS-1 rodents 
not recommended for long-term development 
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CARDIOVASCULAR SENSORlTRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood flow 
SENSOWRANSDUCER TYPE: Ultrasound, transit-time 
MEASUREMENT SITEWESSEL: Arteries and veins of various sizes 
A'I"TACHMENT/IMPLANT METHOD: Adjacent to vessel, only loose acoustic 
coupling required 
DEVELOPMENT STATUS: 
1. Near-tern 
available from Transonic Systems, Inc. 
SBIR grant from NIH to develop model for use in 2.5 mm 
telemetry capability within 3-5 years, Westbrook concept 
dia. and lower range 
developed for ARC during FY '87 
2. Long-term 
improvements in packaging, telemetry addition likely 
VLSI, CMOS and signal conditioning R & D required 
ADVANTAGESDIS ADVANTAGES : 
uses pulsed, low-power technique for volume-flow 
currently requires hardwire connection between sensor 
good long-term implant potential 
non-constrictive application, insensitive to angle 
strong industrial and medical interest should support 
and power 
R&D 
RECOMMENDATIONS: 
excellent candidate for near-term development 
monitor improvements already underway by vendor 
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CARDIOVASCULAR SENSCR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood flow 
SENSOIUI’RANSDUCER TYPE: Pulse doppler 
MEASUREMENT SITENESSEL: Arteries and veins of various sizes 
ATTACHMENTflMPLANT METHOD: Crystals held in cuff around vessel 
DEVELOPMENT STATUS: 
1. Near-term 
available, much baseline data, chronically implantable 
Stanford Univ. (Yeung) developing totally implantable system 
for multichannel telemetry, report available soon 
Baylor College of Medicine (Hartley) developing technique 
for measuring cardiac output in rats using subcutaneous 
induction coil for powerhignal conditioning 
work underway on lessening power requirement 
small probes use single crystal 
leads need improvement 
pulsed doppler + B-scan provides flow velocity plus 
dynamic tracking of vessel diameter for volume flow 
est imates  
2. Long-term 
need to reduce cuff size and data transmission bandwidth 
takes less power than similar CW doppler method 
requirements for telemetry 
ADVANTAGESDIS ADVANTAGES: 
cuffs are constrictive of vessel 
improvements are likely in miniaturizing and power 
r e q u i r e m e n t s  
requires complex signal conditioning with relatively 
high power 
flow velocity only, volume flow requires direct imaging of vessel walls 
with precise positioning. 
requires occlusive zero flow calibration 
system is totally implantable 
RECOMMENDATIONS: 
development focus is vague, needs review 
assess B-scan option 
may be superior to CW doppler because of less power, more information 
contained in data (especially gated version) 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood flow 
SENSOWRANSDUCER TYPE: Continuous wave (CW) doppler 
MEASUREMENT SITENESSEL: See pulse doppler 
AT"ACHMENT/IMPLANT METHOD: See pulse doppler 
DEVELOPMENT STATUS: 
1. Near-term - See pulse doppler 
Stanford Univ. has telemetry version 
single crystal available 
2. Long-term - See pulse doppler 
ADVANTAGESDIS ADVANTAGES: 
has flown in space (Cosmos 1514, 1667 biosatellites) 
signal conditioning more complex than pulse doppler 
applicable to very small vessels 
flow velocity only, volume flow requires vessel thickness estimates so 
accuracy compromised 
RECOh4MENDATIONS: 
near term development candidate but pulse doppler is similar and may 
be preferable (see above) 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood flow 
SENSOWRANSDUCER TYPE: Optical laser doppler 
MEASUREMENT SITENESSEL: See pulse doppler 
A'ITACHMENTbMPLANT METHOD: See pulse doppler 
DEVELOPMENT STATUS: 
1. Near-term 
currently beyond state-of-art 
2. Long-term 
could embcd fibers into organ tissue to get regional perfusion data 
much development required 
ADVANTAGESDISADVANTAGES: TBD 
RECOMMENDATIONS: 
not a good candidate for early development. 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Blood flow 
SENSORlTRANSDUCER TYPE: Thermal dilution, microsphere 
MEASUREMENT SITENESSEL: See recommendations below 
ATTACHMENT/IMPLANT METHOD: See recommendations below 
DEVELOPMENT STATUS: See recommendations below 
1. Near-term 
Nejad and Ogden reported a technique for rodents in a NASA 
publication 15 years ago. 
2. Long-term 
Minimal change anticipated 
ADVANTAGESDISADVANTAGES: See recommendations below 
RECOMMENDATIONS: 
*Both techniques currently not applicable to spaceflight constraints due 
to one or more of the following: substantial requirements for 
specimen restraint, anesthesia, vascular injection, one-time 
measurement, specimen sacrifice, and/or complex sensor 
development .  
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CARDIOVASCULAR SENSORITRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Cardiac dimensions 
SENSOWRANSDUCER TYPE: Ultrasonic crystals 
MEASUREMENT SITEWESSEL: Surface of heart 
ATTACHMENTflMPLANT METHOD: Sutured to surface of heart 
DEVELOPMENT STATUS: 
1. Near-term 
available technology, but chronic implant needs 
transit-time dimension gauges (sonomicrometer) and gated 
development  
doppler probes have been used 
2. Long-term 
needs much development for simplifying circuitry and 
biocompatability for long-term implants 
ADVANTAGESDIS ADVANTAGES : 
well-developed technology 
complex circuitry required 
currently needs to be hardwired 
may interfere with flow sensors of same type if in same 
location if operational cycling not possible 
RECOh4MENDATIONS: 
testing required for assessing long-term implant 
evaluate power requirements 
biocompatibility and capabilities for total implantation 
of sensors 
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CARDIOVASCULAR SENSORlTRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Cardiac dimensions 
SENSOWRANSDUCER TYPE: Piezoelectric film 
MEASUREMENT SITE/VESSEL: Surface of heart 
ATTACHMENTfiMPLANT METHOD: 
DEVELOPMENT STATUS : 
1. Near-term 
2. Long-term 
ADVANTAGESDISADVANTAGES: See recommendations below 
RECOMMENDATIONS: 
Sutured to surface of heart 
See recommendations below 
Very early conceptual stage, applicability to 
cardiac dimensions measurement is TBD. 
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CARDIOVASCULAR SENSORlTRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Cardiac dimensions 
SENSOR/TRANSDUCER TYPE: Imaging ultrasound, Fast CT, MRI 
MEASUREMENT SITE/VESSEL: Cardiac chambers 
ATTACHMENTflMPLANT METHOD: External sensors placed adjacent to 
thorax at various distances 
DEVELOPMENT STATUS: 
1. Near-term 
well-developed technologies for human studies and used 
require highly-restrained or  tranquilized animal specimens 
applicable to pre/postflight studies when subjects can be 
with larger animal specimens 
easily handled and/or tranquilized 
2. Long-term 
will require dramatic advance in miniaturization of 
systems and less constraints on movement of specimen 
to be useful in space flight 
ADVANTAGES/DIS ADVANTAGES : 
good cross-over to human studies 
technologies currently not applicable to inflight animal 
MRI may be incompatible with metallic implants in 
may interfere with flow sensors 
s tudies  
spec imens  
RECOMMENDATIONS: 
consider for pre/postflight studies now 
major technology advances required for consideration as 
in fligh t sy s tems. 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Microcirculation of tissues 
SENSOR/I'RANSDUCER TYPE: 
MEASUREMENT SITE/VESSEL: Vascular beds 
Video sensor, laser doppler 
ATTACHMENTDMPLANT METHOD: Implanted in tissue adjacent to 
vascular bed or just external to vascular "window" created 
by a chronic muscle flap surgical procedure 
DEVELOPMENT STATUS: See recommendations below 
1. Near-tern 
Pixel arrays currently available for vidco. Commercial laser doppler 
instruments used in humans 
2. Long-term 
High-resolution devices under development 
ADVANTAGESDISADVANTAGES: See recommendations below 
RECOMMENDATIONS: Video technologies are beyond state-of-the-art 
and good candidates only for long-term development. The Japanese have 
reported interest in developing implantable vidco sensors, however. 
Commercial laser doppler instruments should be evaluated. 
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CARDIOVASCULAR SENSOR/TRANSDUCER ASSESSMENT FORM 
MEASUREMENT: Electrocardiogram (EKG) 
SENSORITRANSDUCER TYPE: 2 or 3-lead sensors 
MEASUREMENT SXTENESSEL: Intra or extra-thoracic but subcutaneous 
A'ITACHMENT/IMPLANT METHOD: Surgically implanted in appropriate site for 2 or 3 lead 
(one ground) sensors 
DEVELOPMENT STATUS: 
proven technology 
recent spaceflight telemetry experience by US and Soviets in rodents, squirrel monkeys 
and Rhesus monkeys 
longevity of leads needs improvement 
2. Long-term 
improvements likely in pre-processing of data 
flexible wire electrodes status TBD 
ADVANTAGESDISADVANTAGES : 
artifacts from muscle contraction 
heavy data rate requirement from small animals 
RECOMMENDATIONS: 
assess status of flexible electrodes made from metallic powder embedded in silicone 
rubber 
assessment of longevity of existing systems needed 
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~ I O V A s C U l A R  KEASURBKENTS IN THE SQUIRREL MONKEY (SAIHIRI SCIVREUS) FOR 
nICHT EXPERIl"T 223 (FLUID AND ELECTROLYTE RESPONSE TO WEIGHTLESSNESS IN 
TEE SQUIRREL RONKM) 
X R H O D :  Chronic indwelling ca the te r  
SITE: A b d o m i n a l  aor t .  belov rend  a r t e ry  
M T W :  Catheter is renothane ( in te rna l )  bonded t o  PVC (external); 
f l u i d  f i l l e d  (1:l 100 units/ml heparin:SOa dextrose). 
BAINTPUNCE: Flushed every 2-4 days; cul tured every 1 - 2  veeks; 
rout inely maintained patent and vi thout  infect ion up t o  
2 years i n  our laboratory.  
SWSOR/"SDUCER: LAB: Hevlitt-Packard Hodel 1099 transducer vith 
H o d e l  8805D preamplifier;  data co l lec ted  on 
HP chart drive e i t h e r  continuously o r  a t  
computer driven sample in te rva l ;  data also 
col locted by DEC PDPll34 (HINC) computer 
u s y s t o l i c ,  d i a s t o l i c  and mean pressures.  
STMILITY: Excellent; +/- IQ 
CALIBRATION: By mercury manometer o r  pressure gauge 
INPUNT TECHNIQUE: Full s ter i le  procedure t o  i n s e r t  ca the te r  through 
in t e rna l  i l i a c  a r t e ry  in to  aorta; ca the te r  i s  ex- 
torrulfzed a t  back between shoulder blader;  mesh 
jacket worn a t  a l l  times t o  pro tec t .  
firmed post-surgery by x-ray of cont ras t  f i l l e d  
catbe t.?. 
Posit ion con- 
PREFLXCHT/POSTFIJCHT ACTIVITIES: In or ig ina l  proposal a r t e r i a l  pressure 
would have been measured throughout a 7-10 cont ro l  study three veeks 
beforo and after flight. 
ISSUES: Continuous measurement requires  constant infusion ( f l i g h t  qual 
Infusion system not yet completely designed); periodic 
measurement requires  ca the te r  t o  be flushed (crev time). 
ORlGlNAh PAGE IS 
OF POOR QUALITY 
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CARDI0VASCUIA.R pIEASUREK&NTS CURRENTLY MADE IN GROUND-BASED SQUIRREL HOhXEY 
LBPP MODEL 
o ARTERIALPRESSURE 
o HEARTRATE 
0 CENTRU VENOUS PRESSURE 
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ORIGTNAL PAGE IS 
OF POOR QUALITY 
ALL PAIWfETEBs IDENTICAL 2’0 ARTERIAL PRESSURE EXCEPT: 
SITE: Catheter is inserted through external or common Iliac 
artery into vena cava such that t i p  rests above diaphragm 
and belou right heart. 
STABILITY OF fBAh’SDUCE3: IAB: Poor for long periods of time; 
tcnpcraturt sensitive - vi11 vary +/- 2.5  mm Hg overnight (CVP = 
0-2 m Q). 
FLIGHT: TBD; s t a b i l i t y  (.zero drift’) a 
major problem. 
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Crystal-controlled telemetry system for long-term acquistion of 
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